Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study.

Stephan A C SchoonveldeIsabell WiethoffMickaël HiligsmannSilvia M A A EversMichelle Michels

Published in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2023)

The AFFECT-HCM study will evaluate the BoD in HCM patients and G+/P- subjects to improve the understanding of the societal and economic impact of HCM.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
end stage renal disease
randomized controlled trial
ejection fraction
chronic kidney disease
newly diagnosed
heart failure
prognostic factors
patient reported outcomes